There is no significant difference in the overall 5-year disease-free survival between the treatment arms .
Between May of 1987 and August of 1995  , 234 patients predominantly from two centers  , with others participating  , were stratified by their extent of pelvic disease and randomized to receive one of four possible treatments .
Patients were randomized to receive either (a) standard external beam pelvic irradiation (EBRT) in a dose of 5000 cGy in 25 fractions defined at 100% versus  , (b) RT as in arm (a) with infusional intravenous 5-FU in a dose of 1 g/m2 daily on the first and last 4 days of RT  , (c) partially hyperfractionated RT  , 5280 cGy in 33 fractions  , 2 fractions per day on the first and last 4 days of RT  , or (d) arm (c) with the same infusional 5-FU .
